Paraneoplastic Cerebellar Degeneration Secondary to BRAF Mutant Melanoma Metastasis from an Occult Primary Cancer

Melanoma metastasis from an unknown primary cancer has an incidence of 3.2% among melanoma patients. Furthermore, paraneoplastic neurological syndromes (PNS) are rare, occurring in 1–3% of patients with malignancies. Paraneoplastic cerebellar degeneration (PCD) is one of the classic PNS and is chara...

Full description

Bibliographic Details
Main Authors: Omar Jiménez-Zarazúa, Lourdes Noemí Vélez-Ramírez, María Alcocer-León, Diego Armando Hernández-Domínguez, Juana Elizabeth Tadeo-González, María Andrea Martínez-Rivera, Martín Daniel Alejandro López-González, Sandra Xaviera Lizeth Tafoya-Rojas, Jaime Daniel Mondragón
Format: Article
Language:English
Published: Karger Publishers 2020-06-01
Series:Case Reports in Oncology
Subjects:
Online Access:https://www.karger.com/Article/FullText/507729
_version_ 1828266156481314816
author Omar Jiménez-Zarazúa
Lourdes Noemí Vélez-Ramírez
María Alcocer-León
Diego Armando Hernández-Domínguez
Juana Elizabeth Tadeo-González
María Andrea Martínez-Rivera
Martín Daniel Alejandro López-González
Sandra Xaviera Lizeth Tafoya-Rojas
Jaime Daniel Mondragón
author_facet Omar Jiménez-Zarazúa
Lourdes Noemí Vélez-Ramírez
María Alcocer-León
Diego Armando Hernández-Domínguez
Juana Elizabeth Tadeo-González
María Andrea Martínez-Rivera
Martín Daniel Alejandro López-González
Sandra Xaviera Lizeth Tafoya-Rojas
Jaime Daniel Mondragón
author_sort Omar Jiménez-Zarazúa
collection DOAJ
description Melanoma metastasis from an unknown primary cancer has an incidence of 3.2% among melanoma patients. Furthermore, paraneoplastic neurological syndromes (PNS) are rare, occurring in 1–3% of patients with malignancies. Paraneoplastic cerebellar degeneration (PCD) is one of the classic PNS and is characterized by acute or subacute onset of ataxia and/or presence of onconeural antibodies. A 61-year-old male with ataxia, vertigo, and headache later developed dysarthria, multidirectional nystagmus, hyperactive delirium, auditory hallucinations, psychomotor agitation, and myoclonus. Toxicological, metabolic, infectious, and autoimmune etiologies were assessed and reported negative. An osteolytic lesion was observed in the right iliac crest via computed tomography (CT). A positron emission tomography-CT reported increased fluorodeoxyglucose uptake of a right iliac and right inguinal ganglion. After biopsy of the right inguinal ganglion, a BRAF mutation-positive melanoma metastasis from an occult primary cancer was diagnosed. Dermatologic, ophthalmologic, and endoscopic gastrointestinal assessment did not reveal a primary malignant melanoma. The patient’s movement disorders and neuropsychiatric symptoms improved with quetiapine, prednisone, azathioprine, and cyclophosphamide. Oncological management was conducted with MAPK pathway inhibitors (i.e., dabrafenib and trametinib). Movement disorders associated with neuropsychiatric symptoms are complex to diagnose. PNS are rare and often associated with antibodies against neural antigens expressed by the tumor. The case presented above describes a patient with a BRAF-positive malignant melanoma metastasis from an occult primary associated with PCD – to the best of our knowledge, the first reported in the literature.
first_indexed 2024-04-13T04:49:11Z
format Article
id doaj.art-cf3f3ea7b04c42e6bb8ba31430c3ead9
institution Directory Open Access Journal
issn 1662-6575
language English
last_indexed 2024-04-13T04:49:11Z
publishDate 2020-06-01
publisher Karger Publishers
record_format Article
series Case Reports in Oncology
spelling doaj.art-cf3f3ea7b04c42e6bb8ba31430c3ead92022-12-22T03:01:45ZengKarger PublishersCase Reports in Oncology1662-65752020-06-0113263364210.1159/000507729507729Paraneoplastic Cerebellar Degeneration Secondary to BRAF Mutant Melanoma Metastasis from an Occult Primary CancerOmar Jiménez-ZarazúaLourdes Noemí Vélez-RamírezMaría Alcocer-LeónDiego Armando Hernández-DomínguezJuana Elizabeth Tadeo-GonzálezMaría Andrea Martínez-RiveraMartín Daniel Alejandro López-GonzálezSandra Xaviera Lizeth Tafoya-RojasJaime Daniel MondragónMelanoma metastasis from an unknown primary cancer has an incidence of 3.2% among melanoma patients. Furthermore, paraneoplastic neurological syndromes (PNS) are rare, occurring in 1–3% of patients with malignancies. Paraneoplastic cerebellar degeneration (PCD) is one of the classic PNS and is characterized by acute or subacute onset of ataxia and/or presence of onconeural antibodies. A 61-year-old male with ataxia, vertigo, and headache later developed dysarthria, multidirectional nystagmus, hyperactive delirium, auditory hallucinations, psychomotor agitation, and myoclonus. Toxicological, metabolic, infectious, and autoimmune etiologies were assessed and reported negative. An osteolytic lesion was observed in the right iliac crest via computed tomography (CT). A positron emission tomography-CT reported increased fluorodeoxyglucose uptake of a right iliac and right inguinal ganglion. After biopsy of the right inguinal ganglion, a BRAF mutation-positive melanoma metastasis from an occult primary cancer was diagnosed. Dermatologic, ophthalmologic, and endoscopic gastrointestinal assessment did not reveal a primary malignant melanoma. The patient’s movement disorders and neuropsychiatric symptoms improved with quetiapine, prednisone, azathioprine, and cyclophosphamide. Oncological management was conducted with MAPK pathway inhibitors (i.e., dabrafenib and trametinib). Movement disorders associated with neuropsychiatric symptoms are complex to diagnose. PNS are rare and often associated with antibodies against neural antigens expressed by the tumor. The case presented above describes a patient with a BRAF-positive malignant melanoma metastasis from an occult primary associated with PCD – to the best of our knowledge, the first reported in the literature.https://www.karger.com/Article/FullText/507729melanomanervous system paraneoplastic syndromeoccult primary neoplasmparaneoplastic cerebellar degenerationproto-oncogene protein b-raf
spellingShingle Omar Jiménez-Zarazúa
Lourdes Noemí Vélez-Ramírez
María Alcocer-León
Diego Armando Hernández-Domínguez
Juana Elizabeth Tadeo-González
María Andrea Martínez-Rivera
Martín Daniel Alejandro López-González
Sandra Xaviera Lizeth Tafoya-Rojas
Jaime Daniel Mondragón
Paraneoplastic Cerebellar Degeneration Secondary to BRAF Mutant Melanoma Metastasis from an Occult Primary Cancer
Case Reports in Oncology
melanoma
nervous system paraneoplastic syndrome
occult primary neoplasm
paraneoplastic cerebellar degeneration
proto-oncogene protein b-raf
title Paraneoplastic Cerebellar Degeneration Secondary to BRAF Mutant Melanoma Metastasis from an Occult Primary Cancer
title_full Paraneoplastic Cerebellar Degeneration Secondary to BRAF Mutant Melanoma Metastasis from an Occult Primary Cancer
title_fullStr Paraneoplastic Cerebellar Degeneration Secondary to BRAF Mutant Melanoma Metastasis from an Occult Primary Cancer
title_full_unstemmed Paraneoplastic Cerebellar Degeneration Secondary to BRAF Mutant Melanoma Metastasis from an Occult Primary Cancer
title_short Paraneoplastic Cerebellar Degeneration Secondary to BRAF Mutant Melanoma Metastasis from an Occult Primary Cancer
title_sort paraneoplastic cerebellar degeneration secondary to braf mutant melanoma metastasis from an occult primary cancer
topic melanoma
nervous system paraneoplastic syndrome
occult primary neoplasm
paraneoplastic cerebellar degeneration
proto-oncogene protein b-raf
url https://www.karger.com/Article/FullText/507729
work_keys_str_mv AT omarjimenezzarazua paraneoplasticcerebellardegenerationsecondarytobrafmutantmelanomametastasisfromanoccultprimarycancer
AT lourdesnoemivelezramirez paraneoplasticcerebellardegenerationsecondarytobrafmutantmelanomametastasisfromanoccultprimarycancer
AT mariaalcocerleon paraneoplasticcerebellardegenerationsecondarytobrafmutantmelanomametastasisfromanoccultprimarycancer
AT diegoarmandohernandezdominguez paraneoplasticcerebellardegenerationsecondarytobrafmutantmelanomametastasisfromanoccultprimarycancer
AT juanaelizabethtadeogonzalez paraneoplasticcerebellardegenerationsecondarytobrafmutantmelanomametastasisfromanoccultprimarycancer
AT mariaandreamartinezrivera paraneoplasticcerebellardegenerationsecondarytobrafmutantmelanomametastasisfromanoccultprimarycancer
AT martindanielalejandrolopezgonzalez paraneoplasticcerebellardegenerationsecondarytobrafmutantmelanomametastasisfromanoccultprimarycancer
AT sandraxavieralizethtafoyarojas paraneoplasticcerebellardegenerationsecondarytobrafmutantmelanomametastasisfromanoccultprimarycancer
AT jaimedanielmondragon paraneoplasticcerebellardegenerationsecondarytobrafmutantmelanomametastasisfromanoccultprimarycancer